Price T Rowe Associates Inc Teva Pharmaceutical Industries LTD Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Price T Rowe Associates Inc holds 825,431 shares of TEVA stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

825,431

Previous 254,129 224.81%

Holding current value

$14.1 Million

Previous $4.13 Million 260.17%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $9.03 Million - $10.8 Million	571,302 Added 224.81%	825,431 $14.9 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $668,138 - $909,671	52,280 Added 25.9%	254,129 $4.13 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $387,267 - $523,736	36,295 Added 21.92%	201,849 $2.85 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $114,491 - $149,883	14,100 Added 9.31%	165,554 $1.73 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $83,028 - $118,769	11,100 Added 7.91%	151,454 $1.55 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $26,863 - $35,332	3,731 Added 2.73%	140,354 $1.06 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $100,261 - $136,360	11,993 Added 9.62%	136,623 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $46,905 - $55,932	5,900 Added 4.97%	124,630 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $4.12 Million - $7.17 Million	-600,174 Reduced 83.48%	118,730 $959,000
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $503,234 - $709,165	68,189 Added 10.48%	718,904 $5.41 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $850,521 - $1.09 Million	116,033 Added 21.7%	650,715 $6.11 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $204,230 - $263,431	25,852 Added 5.08%	534,682 $4.28 Million
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $75,420 - $91,620	-9,000 Reduced 1.74%	508,830 $4.96 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $4.04 Million - $4.72 Million	407,900 Added 371.05%	517,830 $5.13 Million
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $38,258 - $47,397	3,700 Added 3.48%	109,930 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $914,640 - $1.17 Million	106,230 New	106,230 $1.03 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Teva Pharmaceutical Industries LTD Transaction History